Loading...
KRT6A Antibody

35628

KRT6A Antibody

KRT6A Antibody (catalogue number 35628) is a rabbit-derived primary antibody validated for Immunohistochemistry, reactive with Human samples. It targets Keratin, type II cytoskeletal 6A (KRT6A): Structural component of intermediate filaments in epithelial keratinocytes. Supplied as 100ul at ₪1,301.17; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
Immunohistochemistry
UniProt ID
P02538
Gene
KRT6A
Target organism
Homo sapiens
Catalogue number
35628
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Keratin, type II cytoskeletal 6A (KRT6A) · Homo sapiens

Structural component of intermediate filaments in epithelial keratinocytes. Forms heteropolymers with the type I keratins KRT16 and KRT17, assembling into keratin intermediate filament networks that contributes to the structural integrity and stress resilience of stratified epithelia, particularly in epidermis, nail bed and oral mucosa. Rapidly induced in wound-edge keratinocytes and participates in cytoskeletal reorganization during re-epithelialization.

Subcellular location: Cytoplasm

Tissue specificity: Expressed in the corneal epithelium (at protein level)

Sequence length: 564 aa · 60045 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.